{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T12:06:03Z","timestamp":1784549163559,"version":"3.55.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:00:00Z","timestamp":1780704000000},"content-version":"vor","delay-in-days":36,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.rpth.2026.106794","type":"journal-article","created":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T01:11:09Z","timestamp":1781313069000},"page":"106794","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Should we focus on sustainable thromboprophylaxis and avoid overuse of low-molecular-weight heparins?"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-0808-8779","authenticated-orcid":false,"given":"Gerard","family":"Gurumurthy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingwen Eugene","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juditha","family":"Gurumurthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Lippi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel J.","family":"Favaloro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jecko","family":"Thachil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpth.2026.106794_bib1","series-title":"Preventing Hospital-Associated Venous Thromboembolism: A Guide for Effective Quality Improvement. AHRQ Publication No. 16-001-EF","author":"Maynard","year":"2016"},{"key":"10.1016\/j.rpth.2026.106794_bib2","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s11239-015-1265-8","article-title":"Prescription of enoxaparin is associated with decreasing pulmonary embolism mortality rate in Germany","volume":"40","author":"P\u00fctter","year":"2015","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.rpth.2026.106794_bib3","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.addr.2015.11.002","article-title":"Bioengineered heparins and heparan sulfates","volume":"97","author":"Fu","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.rpth.2026.106794_bib4","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/jth.15607","article-title":"An update on the global use of risk assessment models and thromboprophylaxis in hospitalized patients with medical illnesses from the World Thrombosis Day steering committee: systematic review and meta-analysis","volume":"20","author":"Forgo","year":"2022","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106794_bib5","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/MBC.0000000000000100","article-title":"Impact of the national venous thromboembolism risk assessment tool in secondary care in England: retrospective population-based database study","volume":"25","author":"Catterick","year":"2014","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.rpth.2026.106794_bib6","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/jhm.13385","article-title":"Venous thromboembolism performance measurement in the United States: an evolving landscape with many stakeholders","volume":"19","author":"Braun","year":"2024","journal-title":"J Hosp Med"},{"key":"10.1016\/j.rpth.2026.106794_bib7","series-title":"The Surgeon General\u2019s Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism","year":"2008"},{"key":"10.1016\/j.rpth.2026.106794_bib8","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1007\/s11606-020-05993-x","article-title":"Overuse of primary thromboprophylaxis in medical inpatients at low risk of venous thromboembolism","volume":"36","author":"Djulbegovic","year":"2021","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.rpth.2026.106794_bib9","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1001\/archinte.162.11.1245","article-title":"Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study","volume":"162","author":"Heit","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.rpth.2026.106794_bib10","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1182\/bloodadvances.2018022954","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients","volume":"2","author":"Sch\u00fcnemann","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2026.106794_bib11","doi-asserted-by":"crossref","first-page":"625","DOI":"10.7326\/0003-4819-155-9-201111010-00011","article-title":"Venous thromboembolism prophylaxis in hospitalized patients: a clinical practice guideline from the American College of Physicians","volume":"155","author":"Qaseem","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rpth.2026.106794_bib12","doi-asserted-by":"crossref","DOI":"10.1136\/bmjmed-2022-000408","article-title":"Effectiveness and cost effectiveness of pharmacological thromboprophylaxis for medical inpatients: decision analysis modelling study","volume":"3","author":"Davis","year":"2024","journal-title":"BMJ Med"},{"key":"10.1016\/j.rpth.2026.106794_bib14","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s11606-011-1871-x","article-title":"Unintended consequences of a standard admission order set on venous thromboembolism prophylaxis and patient outcomes","volume":"27","author":"Khanna","year":"2012","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.rpth.2026.106794_bib15","doi-asserted-by":"crossref","first-page":"41","DOI":"10.12688\/f1000research.2-41.v1","article-title":"Has incentive payment improved venous thrombo-embolism risk assessment and treatment of hospital in-patients?","volume":"2","author":"Child","year":"2013","journal-title":"F1000Res"},{"key":"10.1016\/j.rpth.2026.106794_bib16","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2012-001668","article-title":"Challenges in implementing government-directed VTE guidance for medical patients: a mixed methods study","volume":"2","author":"Basey","year":"2012","journal-title":"BMJ Open"},{"key":"10.1016\/j.rpth.2026.106794_bib17","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.2146\/ajhp090575","article-title":"Effects of clinical decision support on venous thromboembolism risk assessment, prophylaxis, and prevention at a university teaching hospital","volume":"67","author":"Galanter","year":"2010","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.rpth.2026.106794_bib18","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1160\/TH09-09-0634","article-title":"Multi-screen electronic alerts to augment venous thromboembolism prophylaxis","volume":"103","author":"Fiumara","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106794_bib19","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1111\/jth.13687","article-title":"A decision model to estimate a risk threshold for venous thromboembolism prophylaxis in hospitalized medical patients","volume":"15","author":"Le","year":"2017","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106794_bib21","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/jhm.399","article-title":"Medical admission order sets to improve deep vein thrombosis prophylaxis rates and other outcomes","volume":"4","author":"O\u2019Connor","year":"2009","journal-title":"J Hosp Med"},{"key":"10.1016\/j.rpth.2026.106794_bib22","doi-asserted-by":"crossref","first-page":"e317","DOI":"10.1055\/s-0044-1790519","article-title":"Impact of clinical decision support with mandatory versus voluntary venous thromboembolism risk assessment in hospitalized patients","volume":"8","author":"Bahl","year":"2024","journal-title":"TH Open"},{"key":"10.1016\/j.rpth.2026.106794_bib23","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/jhm.13104","article-title":"Initiative to reduce inappropriate venous thromboembolism prophylaxis in an 11-hospital safety net system: an electronic health records-based approach","volume":"18","author":"Haller","year":"2023","journal-title":"J Hosp Med"},{"key":"10.1016\/j.rpth.2026.106794_bib24","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1378\/chest.13-0267","article-title":"Comprehensive VTE prevention program incorporating mandatory risk assessment reduces the incidence of hospital-associated thrombosis","volume":"144","author":"Roberts","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.rpth.2026.106794_bib26","doi-asserted-by":"crossref","first-page":"403","DOI":"10.12788\/jhm.2916","article-title":"Poor adherence to risk stratification guidelines results in overuse of venous thromboembolism prophylaxis in hospitalized older adults","volume":"13","author":"Pavon","year":"2018","journal-title":"J Hosp Med"},{"key":"10.1016\/j.rpth.2026.106794_bib27","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1160\/TH14-06-0525","article-title":"Predictors of thromboprophylaxis in hospitalised medical patients. Explicit ASsessment of Thromboembolic RIsk and Prophylaxis for Medical PATients in SwitzErland (ESTIMATE)","volume":"113","author":"Spirk","year":"2015","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106794_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2023.102184","article-title":"Overuse and underuse of thromboprophylaxis in medical inpatients","volume":"7","author":"Kocher","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106794_bib29","first-page":"299","article-title":"Appropriateness of pharmacologic thromboprophylaxis prescribing based on Padua score among inpatiet veterans","volume":"39","author":"Creith","year":"2022","journal-title":"Fed Pract"},{"key":"10.1016\/j.rpth.2026.106794_bib30","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1016\/j.jtha.2024.08.016","article-title":"Factors associated with venous thromboembolism pharmacoprophylaxis initiation in hospitalized medical patients: the Medical Inpatients Thrombosis and Hemostasis study","volume":"22","author":"Repp","year":"2024","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106794_bib31","article-title":"Venous thromboembolism prophylaxis in medical and surgical patients \u2013 what\u2019s our reality?","volume":"15","author":"Rocha","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.rpth.2026.106794_bib32","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1001\/jamainternmed.2014.3384","article-title":"Hospital performance for pharmacologic venous thromboembolism prophylaxis and rate of venous thromboembolism: a cohort study","volume":"174","author":"Flanders","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.rpth.2026.106794_bib25","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1001\/jamainternmed.2018.2022","article-title":"Use of venous thromboembolism prophylaxis in hospitalized patients","volume":"178","author":"Grant","year":"2018","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.rpth.2026.106794_bib33","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJM199909093411103","article-title":"A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients","volume":"341","author":"Samama","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rpth.2026.106794_bib34","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/bmj.38733.466748.7C","article-title":"Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial","volume":"332","author":"Cohen","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.rpth.2026.106794_bib35","doi-asserted-by":"crossref","first-page":"602","DOI":"10.7326\/0003-4819-155-9-201111010-00008","article-title":"Venous thromboembolism prophylaxis in hospitalized medical patients and those with stroke: a background review for an American College of Physicians clinical practice guideline","volume":"155","author":"Lederle","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rpth.2026.106794_bib36","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/jhm.450","article-title":"How complete is the evidence for thromboembolism prophylaxis in general medicine patients? A meta-analysis of randomized controlled trials","volume":"4","author":"Bump","year":"2009","journal-title":"J Hosp Med"},{"key":"10.1016\/j.rpth.2026.106794_bib37","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1001\/archinte.167.14.1476","article-title":"Pharmacological venous thromboembolism prophylaxis in hospitalized medical patients: a meta-analysis of randomized controlled trials","volume":"167","author":"Wein","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.rpth.2026.106794_bib38","doi-asserted-by":"crossref","first-page":"e469","DOI":"10.1016\/S2352-3026(22)00171-5","article-title":"Counting the carbon cost of heparin: an evolving tragedy of the commons?","volume":"9","author":"Fan","year":"2022","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.rpth.2026.106794_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2023.168112","article-title":"A systematic review of life-cycle GHG emissions from intensive pig farming: accounting and mitigation","volume":"907","author":"Zhang","year":"2024","journal-title":"Sci Total Environ"},{"key":"10.1016\/j.rpth.2026.106794_bib39","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.3390\/molecules22061025","article-title":"From farm to pharma: an overview of industrial heparin manufacturing methods","volume":"22","author":"Van Der Meer","year":"2017","journal-title":"Molecules"},{"issue":"Suppl 3","key":"10.1016\/j.rpth.2026.106794_bib41","first-page":"5","article-title":"Production and chemical processing of low molecular weight heparins","volume":"25","author":"Linhardt","year":"1999","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.rpth.2026.106794_bib43","doi-asserted-by":"crossref","first-page":"e918","DOI":"10.1016\/S2352-3026(25)00204-2","article-title":"Sustainable anticoagulation for climate resilient care","volume":"12","author":"Fan","year":"2025","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.rpth.2026.106794_bib42","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1177\/0267659112462274","article-title":"The heparin recall of 2008","volume":"28","author":"Hedlund","year":"2013","journal-title":"Perfusion"},{"key":"10.1016\/j.rpth.2026.106794_bib44","doi-asserted-by":"crossref","first-page":"e195S","DOI":"10.1378\/chest.11-2296","article-title":"Prevention of VTE in nonsurgical patients","volume":"141","author":"Kahn","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.rpth.2026.106794_bib45","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.9980","article-title":"Risk assessment models for venous thromboembolism in medical inpatients","volume":"7","author":"H\u00e4fliger","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.rpth.2026.106794_bib46","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1007\/s11606-025-09592-6","article-title":"Use of a risk assessment model for venous thromboembolism is associated with decreased prophylaxis","volume":"40","author":"Gunaratne","year":"2025","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.rpth.2026.106794_bib47","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1016\/j.jtha.2026.02.004","article-title":"What constitutes high risk for venous thromboembolism? Determining an appropriate threshold to initiate prophylaxis","volume":"24","author":"Mittman","year":"2026","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106794_bib48","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.3390\/jcm13072133","article-title":"System-wide thromboprophylaxis interventions for hospitalized patients at risk of venous thromboembolism: focus on cross-platform clinical decision support","volume":"13","author":"Tsaftaridis","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.rpth.2026.106794_bib49","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s11239-009-0405-4","article-title":"Designing and implementing effective venous thromboembolism prevention protocols: lessons from collaborative efforts","volume":"29","author":"Maynard","year":"2010","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.rpth.2026.106794_bib50","doi-asserted-by":"crossref","first-page":"4997","DOI":"10.3390\/jcm11174997","article-title":"Assessment of the effect on thromboprophylaxis with multifaceted quality improvement intervention based on clinical decision support system in hospitalized patients: a pilot study","volume":"11","author":"Gao","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.rpth.2026.106794_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2024.102441","article-title":"Validation of the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) risk scores for venous thromboembolism and bleeding in an independent population","volume":"8","author":"Wilkinson","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106794_bib52","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1046\/j.1538-7836.2003.00396.x","article-title":"The cost-effectiveness of fondaparinux compared with enoxaparin as prophylaxis against thromboembolism following major orthopedic surgery","volume":"1","author":"Gordois","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106794_bib53","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMoa1006885","article-title":"Apixaban versus enoxaparin for thromboprophylaxis after hip replacement","volume":"363","author":"Lassen","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rpth.2026.106794_bib54","first-page":"1781","article-title":"Carbon footprint of direct oral anticoagulants in atrial fibrillation and venous thromboembolism","volume":"111","author":"Chery","year":"2026","journal-title":"Haematologica"},{"key":"10.1016\/j.rpth.2026.106794_bib55","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1055\/a-2712-3534","article-title":"Nonanticoagulant strategies for venous thromboembolism prophylaxis","volume":"52","author":"Gurumurthy","year":"2026","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.rpth.2026.106794_bib56","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1056\/NEJMoa2113194","article-title":"Milvexian for the prevention of venous thromboembolism","volume":"385","author":"Weitz","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rpth.2026.106794_bib57","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1056\/NEJMoa2105872","article-title":"Abelacimab for Prevention of Venous Thromboembolism","volume":"385","author":"Verhamme","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rpth.2026.106794_bib58","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1001\/jama.2019.20687","article-title":"Effect of osocimab in preventing venous thromboembolism among patients undergoing knee arthroplasty: the FOXTROT randomized clinical trial","volume":"323","author":"Weitz","year":"2020","journal-title":"JAMA"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037926034527?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037926034527?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:22:15Z","timestamp":1784546535000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037926034527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2475037926034527"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2026.106794","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Should we focus on sustainable thromboprophylaxis and avoid overuse of low-molecular-weight heparins?","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2026.106794","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"106794"}}